Date lodged: 14 December 2017
To ask the Scottish Government what discussions NHS National Services Scotland has had with the Scottish Medicines Consortium regarding funding the use of KUVAN for the treatment of phenylketonuria.
Answered by: Shona Robison 20 December 2017
NHS National Services Scotland has confirmed that they have had no discussions with the Scottish Medicines Consortium (SMC) in relation to funding for the use of Kuvan.
Kuvan’s manufacturer, BioMarin, have been involved in communications with the SMC and any decision over whether or not to make a submissions to the SMC is purely one for BioMarin.